LB Pharmaceuticals Inc (LBRX) stock
LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$40.30−2.69 (-6.26%)
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
LB Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
LB Pharmaceuticals's pe ratio was 0.2× on Jan 30, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 0.2× | −0.0 |
| 2025 | Dec 31, 2025 | 0.2× | – |
See a number that looks wrong?